Oral Sabizabulin for High-Risk, Hospitalized Adults with Covid-19: Interim Analysis.
Barnette KG, Gordon MS, Rodriguez D, Bird TG, Skolnick A, Schnaus M, Skarda PK, Lobo S, Sprinz E, Arabadzhiev G, Kalaydzhiev P, Steiner M.
Barnette KG, et al.
NEJM Evid. 2022 Sep;1(9):EVIDoa2200145. doi: 10.1056/EVIDoa2200145. Epub 2022 Jul 6.
NEJM Evid. 2022.
PMID: 38319812